Showing 1461-1470 of 10035 results for "".
DermWireTV: LEO Science & Tech Hub, Allergan/SkinBetter DREAM Initiative, San Diego Dermatology Symposium
https://practicaldermatology.com/topics/skin-cancer-photoprotection/dermwiretv-leo-pharma-science-tech-hub-allerganskinbetter-dream-initiative-san-diego-dermatology-symposium/19856/Innovation Endeavors and the LEO Science & Tech Hub kick off a Deep Life Challenge program. Allergan Aesthetics, an AbbVie company, and Skinbetter Science launch a new long-term, educational initiative: The DREAM (Driving Racial Equity in Aesthetic Medicine) Initiative. The San Diego DermatologyBristol-Myers Squibb Acquires Celgene, My UV Tracker, More
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-bristol-myers-squibb-acquires-celgene-my-skin-track-uv-more/19534/Bristol-Myers Squibb will acquire Celgene in a cash and stock transaction with an equity value of approximately $74 Billion. Suneva® Medical partners with Healeon Medical, Inc. and Puregraft, LLC to add two new products to its aesthetics portfolio. Unveiled at the 2018 Consumer Electronics Show, theDupixent for Adolescents priority review, Restylane Lyft via cannulas, Hyperhidrosis Awareness
https://practicaldermatology.com/series/dermwire-tv/dermwire-tv-dupixent-for-adolescents-priority-review-restylane-lyft-via-cannulas-hyperhidrosis-awareness/18215/FDA grants priority review for Sanofi's and Regeneron's sBLA for Dupixent (dupilumab) for adolescents. Galderma's Restylane Lyft is approved for use with a small, blunt-tip cannula for cheek augmentation and the correction of age-related midface contour deficiencies in patients over the age of 21. TMedical Derm at Summer AAD; Novel Drugs, Acne at Derm 2018
https://practicaldermatology.com/topics/skin-cancer-photoprotection/dermwiretv-medical-derm-at-summer-aad-novel-drugs-acne-at-derm-2018/18244/The Summer meeting of the American Academy of Dermatology (AAD) gathers members for updates on medical and aesthetic advancements. This year, topics included advanced therapeutics, skin cancer, and skin of color. DERM 2018 provides an opportunity for nurse practitioners and physician assistants in dBrightGuard Covers NYC, Galderma Uncovers Rosacea Burden, Dermira's Qbrexza Approved
https://practicaldermatology.com/series/dermwire-tv/dermwire-tv-brightguard-covers-nyc-galderma-uncovers-rosacea-burden-dermira-s-qbrexza-approved/18288/BrightGuard dispensers have now been installed at 53 public pools and 11 beaches in various locations throughout metropolitan New York. The impact of rosacea can be significant for affected patients. According to survey results released last month by Galderma, 86% of patients with rosacea modify theAAD SkinSerious Campaign, Meeting Highlights; Galderma Partners with Modernizing Medicine
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-aad-skinserious-campaign-meeting-highlights-galderma-partners-with-modernizing-medicine/18515/The American Academy of Dermatology's new SkinSerious campaign is raising awareness about skin disease and the specialty. The Skin Serious initiative kicked off at the AAD Annual Meeting in Orlando this month. New research presented at this year's meeting focused on skin disease prevention and treatValeant's Siliq Cleared, AmSpa Survey, New Skin Cancer Imaging
https://practicaldermatology.com/topics/skin-cancer-photoprotection/dermwiretv-valeant-s-siliq-cleared-amspa-survey-new-skin-cancer-imaging/18527/The FDA has approved Valeant Pharmaceutical's Siliq (brodalumab) injection for subcutaneous use for patients with moderate-to-severe plaque psoriasis. The American Med Spa Association (AmSpa) has extended the deadline for its comprehensive survey of MedSpas nationwide. Multiphoton microscopy of mitoMichael Gold Honored, CSF Highlights, Anxiety Linked to Skin Disease
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-michael-gold-honored-csf-highlights-anxiety-linked-to-skin-disease/18720/From bloodless blephs to nutraceuticals, innovative approaches to patient care take the spotlight at Cosmetic Surgery Forum each year. This year, the meeting introduced new topics and new speakers, says CSF founder and Practical Dermatology Chief Cosmetic Surgery Editor, Dr. Joel Schlessinger. Dr. MAesthetic A-Peel: Using Peels in Practice
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/aesthetic-a-peel-using-peels-in-practice/18556/As devices continue to evolve so do more "conventional" treatments, like peels. Dr. Gilbert talks about advancements in peels and the rise of nutraceuticals.Enstilar Approved; New Data for Otezla, Duac
https://practicaldermatology.com/topics/psoriasis/dermwiretv-enstilar-approved-new-data-for-otezla-duac/18687/LEO Pharma's Enstilar (Calcipotriene and Betamethasone Dipropionate) Foam, 0.005%/0.064% has been FDA-approved for plaque psoriasis. New data presented at EADV on Stiefel's Duac, Celgene's Otezla, and Boehringer Ingelheim's investigational biologic compound BI 655066. Plus, Galderma's OTC Excipial l